UAB "CSO Pharma Baltic" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 312,708 |
| 33,990 |
| 19,230 |
| -19,130 |
| -2,079 |
| 34.19 |
| -6.12 |
| 48,659 |
| 33,912 |
| 12,083 |
| 70,397 |
| 2023 |
|---|
| 420,311 |
| 52,539 |
| 7,873 |
| -7,868 |
| -984 |
| 30.70 |
| -1.87 |
| 40,791 |
| 21,120 |
| 8,175 |
| 55,752 |
| 2024 |
|---|
| 328,261 |
| 65,391 |
| 7,322 |
| 7,322 |
| 1,459 |
| 35.02 |
| 2.23 |
| 48,163 |
| 23,845 |
| 4,404 |
| 70,187 |
Register and
explore Okredo data| 2024 |
|---|
| 328,261 |
| 65,391 |
| 7,322 |
| 7,322 |
| 1,459 |
| 35.02 |
| 2.23 |
| 48,163 |
| 23,845 |
| 4,404 |
| 70,187 |
Register and
explore Okredo data2024
Turnover (€)
328,261 €
-22 % *
Sales per employee (€)
65,391 €
24 % *
Profit before tax (€)
7,322 €-7 % *
Net Profit (€)
7,322 €193 % *
Profit per employee (€)
1,459 €248 % *
Total profitability (%)
35.02 %14.07 % *
Net profitability (%)
2.23 %219.25 % *
Equity (€)
48,163 €18 % *
Amounts Payable And Liabilities (€)
23,845 €
13 % *
Non-current Assets (€)
4,404 €
-46 % *
CurrentAssets (€)
70,187 €26 % *